DOI:
10.1055/s-00000041
Neuropediatrics
LinksClose Window
References
Shefner JM, Wolff AA, Meng L. , et al; ON BEHALF OF THE BENEFIT-ALS STUDY GROUP.
A randomized, placebo-controlled, double-blind phase IIb trial evaluating the safety and efficacy of tirasemtiv in patients with amyotrophic lateral sclerosis.
Amyotroph Lateral Scler Frontotemporal Degener 2016;
17 (5-6): 426-435
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.